Crossmark

High prevalence of epilepsy in two rural onchocerciasis endemic villages in the Mahenge area, Tanzania, after 20 years of community directed treatment with ivermectin

Crossref DOI link: https://doi.org/10.1186/s40249-018-0450-3

Published Online: 2018-06-20

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mmbando, Bruno P.

Suykerbuyk, Patrick

Mnacho, Mohamed

Kakorozya, Advocatus

Matuja, William

Hendy, Adam

Greter, Helena

Makunde, Williams H.

Colebunders, Robert
Funding

Funding for this research was provided by:

European Research Council (ERC 671055)
License Information

Text and Data Mining valid from 2018-06-20
More Information

Article History

Received: 16 January 2018

Accepted: 7 June 2018

First Online: 20 June 2018

Ethics approval and consent to participate

: This study was approved by the ethical committees of the National Institute for Medical Research in Tanzania and the University of Antwerp in Belgium. The study was carried out adhering to the principles of the Declaration of Helsinki. Meetings were held with the community leaders to explain the aims and procedures of the study. During the screening phase, consent was obtained from heads of households or adults who were available at the household during the interviews. For persons suspected to have epilepsy and individuals who participated in REMO and in OV16 testing, individual written consent was obtained. Individuals aged 18 years and above provided their own consent, while children and minors had their consent signed by their parents or guardians. Moreover, assent was obtained from those aged 12 years or above.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below